Ksilometazolinklorid/Ipratropijev Bromid Acino

Xylometazoline Hydrochloride and Ipratropium Bromide, the active ingredients in Ksilometazolinklorid/Ipratropijev Acino, are a combination nasal decongestant and anticholinergic presented as a nasal spray for nasal use. They treat nasal congestion associated with the common cold, allergic rhinitis and acute sinusitis in adults and children.

GNH USA supplies Ksilometazolinklorid/Ipratropijev Acino as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ksilometazolinklorid/Ipratropijev Acino acts on nasal mucosal vessels and glandular secretion to relieve congestion and discharge.

- Common cold nasal congestion: reduces swelling of nasal mucosa and improves airflow. - Allergic rhinitis: decreases nasal secretions and eases blockage. - Acute sinusitis: alleviates sinus pressure by opening nasal passages.

The following adverse reactions have been reported with the nasal spray.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild epistaxis. - Headache. - Altered taste or bitter taste. - Transient nasal itching.

Serious or Rare Side Effects: - Severe nasal bleeding. - Allergic reaction including rash, swelling, or anaphylaxis. - Paradoxical worsening of congestion (rebound congestion). - Cardiac arrhythmia (rare). - Acute glaucoma in susceptible individuals.

Before using Ksilometazolinklorid/Ipratropijev Acino, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and under medical advice. - Children under 2 years: avoid use unless specifically prescribed. - Prolonged use (>7 days): discontinue to prevent rebound congestion. - Recent nasal surgery or trauma: postpone use until healed. - Store at room temperature: keep in the original container, protect from moisture and light.

Ksilometazolinklorid/Ipratropijev Acino may interact with other medicines as follows.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction may increase cardiovascular strain. - Systemic sympathomimetics: potential for excessive blood pressure elevation.

Moderate Interactions (Monitor Closely):\n- Anticholinergic drugs: increased anticholinergic load may cause dry mouth or urinary retention. - Antihistamines: may enhance nasal dryness. - Inhaled beta‑agonists: monitor for tachycardia or palpitations.